Related references
Note: Only part of the references are listed.Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial
Carlo Salvarani et al.
JAMA INTERNAL MEDICINE (2021)
Effects of adjunct treatment with intravenous immunoglobulins on the course of severe COVID-19: results from a retrospective cohort study
Figen Esen et al.
CURRENT MEDICAL RESEARCH AND OPINION (2021)
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
Payam Tabarsi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy
R. S. Raman et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
SARS-CoV-2 and inflammatory responses: From mechanisms to the potential therapeutic use of intravenous immunoglobulin
Silvia Mascolo et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Efficacy of IVIG (intravenous immunoglobulin) for corona virus disease 2019 (COVID-19): A meta-analysis
Huai-rong Xiang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease
Maria Giovanna Danieli et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2021)
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Aldo Bonaventura et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology
Hannah Wunsch
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
Spinello Antinori et al.
AUTOIMMUNITY REVIEWS (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens
Jose-Maria Diez et al.
IMMUNOTHERAPY (2020)
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
Jing Yang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal
Hasan K. Siddiqi et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
Yun Xie et al.
JOURNAL OF INFECTION (2020)
Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series
Negar Mohtadi et al.
VIROLOGY (2020)
Clinical course and mortality risk of severe COVID-19
Paul Weiss et al.
LANCET (2020)
Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: a multicenter, retrospective, observational study
Fan Wu et al.
JOURNAL OF THORACIC DISEASE (2020)
Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?
David M. G. Halpin et al.
LANCET RESPIRATORY MEDICINE (2020)
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
Celestino Sardu et al.
JOURNAL OF CLINICAL MEDICINE (2020)
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
Wei Cao et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
The potential impacts of obesity on COVID-19
Ahmed Abdalazim Dafallah Albashir
CLINICAL MEDICINE (2020)
Pharmaco-Immunomodulatory Therapy in COVID-19
John G. Rizk et al.
DRUGS (2020)
Bloodstream infections in critically ill patients with COVID-19
Daniele Roberto Giacobbe et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis
Marco Francone et al.
EUROPEAN RADIOLOGY (2020)
The Enigma of Endothelium in COVID-19
Savneet Kaur et al.
FRONTIERS IN PHYSIOLOGY (2020)
Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
Annette Langer-Gould et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
Xiaosheng Liu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
Mark Roschewski et al.
SCIENCE IMMUNOLOGY (2020)
The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
Naser Gharebaghi et al.
BMC INFECTIOUS DISEASES (2020)
Obesity and COVID-19: A Perspective from the European Association for the Study of Obesity on Immunological Perturbations, Therapeutic Challenges, and Opportunities in Obesity
Gijs H. Goossens et al.
OBESITY FACTS (2020)
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
Jose Maria Diez et al.
IMMUNOTHERAPY (2020)
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The use of methylprednisolone in COVID-19 patients: A propensity score matched retrospective cohort study
Xiang You et al.
PLOS ONE (2020)
Invasive mechanical ventilation in COVID-19 patient management: the experience with 469 patients in Wuhan
Jing Hua et al.
CRITICAL CARE (2020)
COVID-19 mortality and ICU admission: the Italian experience
Paolo Immovilli et al.
CRITICAL CARE (2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Giovanni Guaraldi et al.
LANCET RHEUMATOLOGY (2020)
Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: a multicenter retrospective cohort study
Ziyun Shao et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Hisham Momattin et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2019)
Evaluation of the Effect of Intravenous Immunoglobulin Dosing on Mortality in Patients with Sepsis: A Network Meta-analysis
Yi Yang et al.
CLINICAL THERAPEUTICS (2019)
IgM-enriched immunoglobulins (Pentaglobin) may improve the microcirculation in sepsis: a pilot randomized trial
Roberta Domizi et al.
ANNALS OF INTENSIVE CARE (2019)
Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin
Mohan S. Maddur et al.
TRENDS IN IMMUNOLOGY (2017)
Monomeric Immunoglobulin A from Plasma Inhibits Human Th17 Responses In Vitro Independent of FcαRI and DC-SIGN
Chaitrali Saha et al.
FRONTIERS IN IMMUNOLOGY (2017)
Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock
Yusuke Iizuka et al.
CRITICAL CARE (2017)
Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease
Pierre Lozeron et al.
MUSCLE & NERVE (2016)
Therapeutic immunoglobulin should be dosed by clinical outcome rather than by body weight in obese patients
J. P. Hodkinson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection
Yaseen M. Arabi et al.
ANNALS OF INTERNAL MEDICINE (2014)
Anti-inflammatory effects of high-dose IgG on TNF-α-activated human coronary artery endothelial cells
Akio Matsuda et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin
Mohan S. Maddur et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study
E. Farbu et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
SARS: Systematic review of treatment effects
Lauren J. Stockman et al.
PLOS MEDICINE (2006)
Effect of maternal anti-HPA-1a antibodies and polyclonal IVIG on the activation status of vascular endothelial cells
CM Radder et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients
JT Wang et al.
EMERGING INFECTIOUS DISEASES (2004)
Share Paper
